questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
Superoxide dismutase
Superoxide dismutase : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Désordres enzymatiques
Superoxyde dismutase
Tests de laboratoire
Superoxyde dismutase
Génétique
Superoxyde dismutase
Symptômes
Superoxyde dismutase
Biopsie
Superoxyde dismutase
Symptômes
5
Symptômes
Superoxyde dismutase
Douleur
Superoxyde dismutase
Symptômes respiratoires
Superoxyde dismutase
Troubles neurologiques
Superoxyde dismutase
Santé de la peau
Superoxyde dismutase
Prévention
5
Prévention
Superoxyde dismutase
Mode de vie
Superoxyde dismutase
Toxines
Superoxyde dismutase
Stress oxydatif
Superoxyde dismutase
Compléments alimentaires
Superoxyde dismutase
Traitements
5
Traitement
Superoxyde dismutase
Antioxydants
Superoxyde dismutase
Thérapie génique
Superoxyde dismutase
Médicaments
Superoxyde dismutase
Nutrition
Superoxyde dismutase
Complications
5
Complications
Superoxyde dismutase
Cancer
Superoxyde dismutase
Maladies respiratoires
Superoxyde dismutase
Maladies cardiovasculaires
Superoxyde dismutase
Vieillissement
Superoxyde dismutase
Facteurs de risque
5
Facteurs de risque
Superoxyde dismutase
Nutrition
Superoxyde dismutase
Tabagisme
Superoxyde dismutase
Stress
Superoxyde dismutase
Maladies héréditaires
Superoxyde dismutase
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Superoxide dismutase : Questions médicales les plus fréquentes",
"headline": "Superoxide dismutase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Superoxide dismutase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2025-02-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Superoxide dismutase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxidoreductases",
"url": "https://questionsmedicales.fr/mesh/D010088",
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases",
"code": {
"@type": "MedicalCode",
"code": "D010088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Superoxide dismutase-1",
"alternateName": "Superoxide Dismutase-1",
"url": "https://questionsmedicales.fr/mesh/D000072105",
"about": {
"@type": "MedicalCondition",
"name": "Superoxide dismutase-1",
"code": {
"@type": "MedicalCode",
"code": "D000072105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.881.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Superoxide dismutase",
"alternateName": "Superoxide Dismutase",
"code": {
"@type": "MedicalCode",
"code": "D013482",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Paulo R Mouro",
"url": "https://questionsmedicales.fr/author/Paulo%20R%20Mouro",
"affiliation": {
"@type": "Organization",
"name": "São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil."
}
},
{
"@type": "Person",
"name": "Vitor B P Leite",
"url": "https://questionsmedicales.fr/author/Vitor%20B%20P%20Leite",
"affiliation": {
"@type": "Organization",
"name": "São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil."
}
},
{
"@type": "Person",
"name": "Jorge Chahine",
"url": "https://questionsmedicales.fr/author/Jorge%20Chahine",
"affiliation": {
"@type": "Organization",
"name": "São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil."
}
},
{
"@type": "Person",
"name": "Mehtap Bayır",
"url": "https://questionsmedicales.fr/author/Mehtap%20Bay%C4%B1r",
"affiliation": {
"@type": "Organization",
"name": "Department of Agricultural Biotechnology, Faculty of Agriculture, Atatürk University, Erzurum, Turkey."
}
},
{
"@type": "Person",
"name": "Erdal Özdemir",
"url": "https://questionsmedicales.fr/author/Erdal%20%C3%96zdemir",
"affiliation": {
"@type": "Organization",
"name": "Department of Agricultural Biotechnology, Faculty of Agriculture, Atatürk University, Erzurum, Turkey."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Involvement of complement peptides C3a and C5a in osteoarthritis pathology.",
"datePublished": "2022-05-20",
"url": "https://questionsmedicales.fr/article/35598724",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.peptides.2022.170815"
}
},
{
"@type": "ScholarlyArticle",
"name": "C5a complement levels in clinical remission AQP4-IgG-positive NMO patients.",
"datePublished": "2023-04-07",
"url": "https://questionsmedicales.fr/article/37024715",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13760-023-02261-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37240105",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24108758"
}
},
{
"@type": "ScholarlyArticle",
"name": "Overexpression of complement C5a indicates poor survival and therapeutic response in metastatic renal cell carcinoma.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36883235",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/03936155231161366"
}
},
{
"@type": "ScholarlyArticle",
"name": "The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis.",
"datePublished": "2022-11-29",
"url": "https://questionsmedicales.fr/article/36399686",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14787210.2022.2150165"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Superoxide dismutase",
"item": "https://questionsmedicales.fr/mesh/D013482"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Superoxide dismutase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Superoxide dismutase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Superoxide dismutase",
"description": "Comment diagnostiquer une déficience en SOD ?\nQuels tests sont utilisés pour évaluer la SOD ?\nLa génétique joue-t-elle un rôle dans le diagnostic ?\nQuels symptômes peuvent indiquer un problème de SOD ?\nPeut-on mesurer la SOD dans les tissus ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Complement+C5a#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Superoxide dismutase",
"description": "Quels sont les symptômes d'une déficience en SOD ?\nLa déficience en SOD cause-t-elle des douleurs ?\nY a-t-il des symptômes respiratoires associés ?\nLes troubles neurologiques sont-ils fréquents ?\nLa déficience en SOD affecte-t-elle la peau ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Complement+C5a#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Superoxide dismutase",
"description": "Comment prévenir les déficiences en SOD ?\nLe mode de vie influence-t-il la SOD ?\nLes toxines environnementales affectent-elles la SOD ?\nLe stress oxydatif peut-il être évité ?\nLes compléments alimentaires sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Complement+C5a#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Superoxide dismutase",
"description": "Quels traitements existent pour la déficience en SOD ?\nLes antioxydants aident-ils à compenser la déficience ?\nLa thérapie génique est-elle une option ?\nDes médicaments spécifiques existent-ils ?\nLes changements alimentaires peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Complement+C5a#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Superoxide dismutase",
"description": "Quelles complications peuvent survenir avec une déficience en SOD ?\nLa déficience en SOD augmente-t-elle le risque de cancer ?\nDes maladies respiratoires peuvent-elles être liées ?\nLes maladies cardiovasculaires sont-elles un risque ?\nY a-t-il un lien avec le vieillissement prématuré ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Complement+C5a#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Superoxide dismutase",
"description": "Quels sont les facteurs de risque pour une déficience en SOD ?\nL'alimentation influence-t-elle la SOD ?\nLe tabagisme affecte-t-il la SOD ?\nLe stress chronique est-il un facteur de risque ?\nLes maladies héréditaires influencent-elles la SOD ?",
"url": "https://questionsmedicales.fr/mesh/D013482?mesh_terms=Complement+C5a#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en SOD ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant l'activité de la SOD peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la SOD ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses biochimiques sont utilisés pour évaluer la SOD."
}
},
{
"@type": "Question",
"name": "La génétique joue-t-elle un rôle dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations affectant la SOD."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème de SOD ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, des douleurs musculaires et des troubles neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer la SOD dans les tissus ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies peuvent être analysées pour mesurer l'activité de la SOD dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en SOD ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, faiblesse musculaire et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "La déficience en SOD cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires et des crampes peuvent être présentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes respiratoires associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes respiratoires peuvent survenir en raison de l'oxydation cellulaire accrue."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques comme des pertes de mémoire peuvent se manifester."
}
},
{
"@type": "Question",
"name": "La déficience en SOD affecte-t-elle la peau ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes cutanés comme le vieillissement prématuré peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déficiences en SOD ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en antioxydants peut aider à prévenir les déficiences."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il la SOD ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant l'exercice, peut améliorer l'activité de la SOD."
}
},
{
"@type": "Question",
"name": "Les toxines environnementales affectent-elles la SOD ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux toxines peut réduire l'activité de la SOD dans l'organisme."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif peut-il être évité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réduire le stress oxydatif par des antioxydants peut aider à préserver la SOD."
}
},
{
"@type": "Question",
"name": "Les compléments alimentaires sont-ils utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains compléments peuvent soutenir la fonction antioxydante de la SOD."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour la déficience en SOD ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments antioxydants et des thérapies géniques peuvent être envisagés."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à compenser la déficience ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antioxydants peuvent réduire les dommages oxydatifs en cas de déficience en SOD."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique vise à corriger les mutations affectant la SOD."
}
},
{
"@type": "Question",
"name": "Des médicaments spécifiques existent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de médicaments spécifiques pour traiter la déficience en SOD."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut soutenir la fonction de la SOD."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en SOD ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des maladies neurodégénératives et des troubles cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "La déficience en SOD augmente-t-elle le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une déficience en SOD peut augmenter le risque de développement de certains cancers."
}
},
{
"@type": "Question",
"name": "Des maladies respiratoires peuvent-elles être liées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies respiratoires comme l'asthme peuvent être exacerbées par une déficience en SOD."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles un risque ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une déficience en SOD peut contribuer à des maladies cardiovasculaires en augmentant le stress oxydatif."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec le vieillissement prématuré ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité réduite de la SOD est associée au vieillissement prématuré des cellules."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour une déficience en SOD ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, l'exposition à des toxines et le vieillissement."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la SOD ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en antioxydants peut augmenter le risque de déficience en SOD."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il la SOD ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le stress oxydatif et peut réduire l'activité de la SOD."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut diminuer l'activité de la SOD et augmenter les dommages cellulaires."
}
},
{
"@type": "Question",
"name": "Les maladies héréditaires influencent-elles la SOD ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques peuvent affecter la production ou l'activité de la SOD."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil.
Center for Theoretical Biological Physics , Rice University , Houston , Texas 77005 , United States.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
São Paulo State University (UNESP), IBILCE , São José do Rio Preto 15054-000 , Brazil.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Agricultural Biotechnology, Faculty of Agriculture, Atatürk University, Erzurum, Turkey.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Agricultural Biotechnology, Faculty of Agriculture, Atatürk University, Erzurum, Turkey.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. prashantdops@gmail.com.
Centre for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Chennai, India. prashantdops@gmail.com.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com.
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com.
Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Allahabad, Allahabad, India.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Molecular Biophysics Group, Institute of Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, L69 7ZB, UK.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Advanced Biomedical Sciences, Medical School, "Federico II" University of Naples, Naples, Italy.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Histopathology, Imperial College London, Hammersmith Hospital, London, United Kingdom.
Publications dans "Superoxide dismutase" :
2 publications dans cette catégorie
Affiliations :
Department of Advanced Biomedical Sciences, Medical School, "Federico II" University of Naples, Naples, Italy.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Department of Food and Nutrition, Brian Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, Korea.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Department of Food and Nutrition, Brian Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, Korea.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Department of Food and Nutrition, Brian Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, Korea.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. kopincova@jfmed.uniba.sk.
Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. kopincova@jfmed.uniba.sk.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. maros.kolomaznik@uniba.sk.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. pavol.mikolka@jfmed.uniba.sk.
Publications dans "Superoxide dismutase" :
1 publication dans cette catégorie
Affiliations :
Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia. petra.kosutova@jfmed.uniba.sk.
Publications dans "Superoxide dismutase" :
Osteoarthritis (OA) affects more than 500 million people worldwide and is among the five diseases in Germany causing the highest suffering of the patients and cost for the society. The quality of life...
Neuromyelitis Optica Spectrum Disorders (NMOSD) is an antibody-mediated disorder of the Central Nervous System where a leading role of the complement system has been demonstrated....
To measure the levels of complement factors C3, C4 and C5a in serum and plasma of clinical remission patients with AQP4-IgG + NMOSD....
Twelve patients with NMOSD AQP4 + according to 2015 criteria from a General Hospital in Buenos Aires, Argentina, were included in the study, and 19 age- and sex-matched healthy volunteers as a control...
The complement factors, C3, C4, and C5a were measured in all samples. The mean concentration of C3 was 130.7 mg/dl (SD 16.1 mg/dl), and the mean concentration of C4 was 21.6 mg/dl (SD 4.8 mg/dl); both...
In conclusion, the present study demonstrates that plasma C5a may be interesting to investigate as a potential biomarker of disease activity in NMOSD, in a larger and prospective cohort....
Diabetic kidney disease (DKD) affects 30-40% of patients with diabetes and is currently the leading cause of end-stage renal disease (ESRD). The activation of the complement cascade, a highly conserve...
Complement C5a is an important component of the innate immune system. An increasing number of reports have revealed the relevance of C5a in tumor progression; however, its exact role in metastatic ren...
We evaluated C5a expression in tumor tissue microarrays of 231 mRCC patients and analyzed the relationship between C5a levels and clinical outcomes, and the expression of epithelial-mesenchymal transi...
High C5a expression was associated with poor therapeutic responses, poor overall and progression-free survival, and high expression of EMT-related proteins and PD-1/PD-L1 in mRCC patients. Exogenous C...
Our findings indicate that elevated C5a expression is associated with poor outcomes in patients with mRCC, and this effect may be partly attributed to the ability of C5a to promote EMT and PD-1/PD-L1 ...
The clinical efficacy and safety of complement C5a inhibitors for patients with severe COVID-19 remains unclear....
The PubMed, Embase, Cochrane Library, and ClinicalTrials.gov databases were searched from their inception to 27 September 2022. Only studies that assessed the usefulness of C5a inhibitors for the trea...
Six studies, including four randomized controlled trials (RCTs) and two non-RCTs, were included. The study group receiving C5a inhibitors had a significantly lower risk of mortality compared with the ...
C5a inhibitors could help reduce the risk of mortality in patients with severe COVID-19 infection while being as safe as placebos. These findings support the promising role of C5a inhibitors in the tr...
Involvement of lower gastrointestinal tract (LGI) occurs in 60% of patients with graft-versus-host-disease (GVHD). Complement components C3 and C5 are involved in GVHD pathogenesis. In this phase 2a s...
Numerous publications have underlined the link between complement C5a and the clinical course of COVID-19. We previously reported that levels of C5a remain high in the group of severely ill patients u...
To examine concentrations of circulating antibodies targeting C3a and C5a complement receptors in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) and analyze their associati...
Concentrations of antibodies against C3a and C5a complement receptors (anti-C3aR and anti-C5aR) and plasma complement fragments C3a and C5a were determined in patients with AAV (n = 110; granulomatosi...
In AAV, anti-C3aR and anti-C5aR antibodies were decreased (P = 0.0026 and P ≤ 0.0001, respectively). In remission, anti-C3aR antibody concentrations rose to values comparable to healthy donors, wherea...
Low concentrations of anti-C5aR antibodies reflect disease activity and are associated with an increased risk for relapse in AAV....
A complement effect on homeostasis during infection is determined by both cytotoxic (activate complement component 5 (C5a) terminal cytotoxic complex (TCC)), and cytoprotective elements (complement fa...
The conjunctiva has immune-responsive properties to protect the eye from infections. Its innate immune system reacts against external pathogens, such as fungi. The complement factor C5a is an importan...